ArticleJTCVS open2026
Patients with high distressed communities index score are at risk for "no-show" to lung cancer screening appointments.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Randomized data support the mortality benefit of lung cancer screening (LCS); however, completion rates among those meeting eligibility criteria remain concerningly low. The Distressed Communities Index (DCI) is a composite socioeconomic metric assessed by ZIP code. We sought to investigate the association between DCI and completion of scheduled LCS appointments. Methods: A retrospective study was conducted in patients scheduled for LCS with low-dose computed tomography at a high-volume center in 2021. Patients were marked as a "no-show" when they missed or canceled their scheduled screening appointment. The association between DCI and screening no-show rates was modeled using a stepwise approach. Results: A total of 1114 patients were scheduled for LCS, of whom 83.5% (n = 928) resided in ZIP codes considered "at-risk" or "distressed" in terms of socioeconomic distress based on their DCI score. In the entire cohort, 18.4% of patients (n = 205) did not attend any screening appointments scheduled within the year. Patients in the "at-risk" and "distressed" categories were more likely to have a no-show (19.5% vs 12%; Conclusions: Higher DCI scores are associated with increased no-show rates for LCS appointments. This tool can be used to target populations at risk of underscreening and associated lung cancer mortality with navigational support or novel interventions to increase screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.